Disability News and Research

RSS

Study reveals dual trends in gallbladder cancer burden worldwide

Announcing a new article publication in BIO Integration. Gallbladder and biliary tract cancers (GBTCs) are highly lethal malignancies with a heterogeneous global burden.

2 Apr 2026

Researchers develop low-cost scalable sensors to study genetic brain disorders

Researchers have demonstrated a new class of low-cost, scalable sensors that can be used to monitor electrical activity in human cerebral organoids.

2 Apr 2026

Lack of dental care linked to higher heart and dementia risk

Being unable to afford dental care may increase a person's risk of developing cardiovascular disease or dementia, according to a new study led by researchers at Boston University School of Public Health (BUSPH).

1 Apr 2026

Mono infection associated with threefold higher multiple sclerosis risk

Having the disease infectious mononucleosis, often called mono, caused by the Epstein-Barr virus is associated with an increased risk of developing multiple sclerosis (MS), according to a study published on April 1, 2026, in Neurology® Open Access, an official journal of the American Academy of Neurology.

1 Apr 2026

Kinesio taping offers limited benefits for treating musculoskeletal pain and mobility

Kinesio taping, or 'KT tape' as it's usually known-widely used to ease joint/muscle pain and boost range of movement-may not be all that effective, suggests a pooled data analysis of the existing evidence, published in the online journal BMJ Evidence Based Medicine.

1 Apr 2026

Plastic chemicals linked to nearly two million premature births

Exposure to a chemical commonly used to make plastic more flexible may have contributed to about 1.97 million preterm births in 2018 alone, or more than 8 percent of the world's total, a new analysis of population surveys shows.

31 Mar 2026

Collaboration advances EMA601 as potential first-in-class stroke therapy

Boehringer Ingelheim and the Lower Franconian biotech company EMFRET Analytics have signed a cooperation and license agreement for the preclinical development program of the GPVI‑blocking antibody EMA601.

30 Mar 2026

Mount Sinai researchers identify a highly prevalent recessive neurodevelopmental disorder

Researchers at the Icahn School of Medicine at Mount Sinai in New York have identified and described a previously unknown recessive neurodevelopmental disorder (NDD) that appears to be the most prevalent ever discovered.

30 Mar 2026

Video modeling interventions enhance romantic relationship skills in young adults with IDD

For too long, individuals with intellectual and developmental disabilities (IDD) have been denied the same opportunities for love, romance and sexual expression as their peers.

27 Mar 2026

University of Chicago and IDefine launch research program to develop Kleefstra syndrome treatment

The University of Chicago Department of Chemistry, in partnership with the advocacy organization IDefine – The Kleefstra Syndrome Foundation, is launching a targeted research program to develop a new potential therapeutic strategy for Kleefstra syndrome (KLEFS).

26 Mar 2026

Mentally active sitting linked to reduced risk of dementia

New research distinguishing between passive and mentally active sitting in association with dementia has found that adults who engaged in extended durations of mentally passive sedentary behaviors had a higher risk of dementia.

26 Mar 2026

Inefficient referral pathways delay lifesaving care for millions of injured people

Many seriously injured patients in Global South countries are failing to reach medical care within the lifesaving 'golden hour' and ambulances are often associated with these delays.

23 Mar 2026

Scientists identify new target to slow Huntington’s disease progression

Huntington's disease is a devastating brain disorder that slowly robs people of movement, memory and personality.

23 Mar 2026

Chronotherapy offers new hope for timing pain relief to match body cycles

Time plays a key role in our perception of pain and administering pain relief and medication for chronic pain-related depression may be more effective at certain times of day, UCL and University of Toronto researchers say.

23 Mar 2026

AI-assisted decision support system improves stroke care and long-term outcomes

A clinical decision support tool that uses artificial intelligence (AI) to analyze scans after a stroke alongside treatment recommendations is associated with better quality care and long term outcomes for patients compared with usual care, finds a study from China published by The BMJ today.

23 Mar 2026

Oral semaglutide fails to slow early Alzheimer’s decline in two phase 3 trials

Two large phase 3 trials found that oral semaglutide 14 mg did not slow cognitive or functional decline over 104 weeks in people with early symptomatic, amyloid-positive Alzheimer’s disease. Semaglutide was generally consistent with its known safety profile and showed some biomarker changes, but these did not translate into clinical benefit.

22 Mar 2026

Oz escalates Medicaid fraud claims against states after focus on Minnesota

The Trump administration has signaled a willingness to halt billions of dollars in federal health payments to multiple states, mirroring moves they made against Minnesota.

20 Mar 2026

New tool helps thousands achieve better blood pressure control

A blood pressure program adopted across the University of California's six academic medical centers has effectively lowered hypertension and prevented serious disease or death for thousands of patients, according to a new study led by UC San Francisco.

18 Mar 2026

Muscle-repairing macrophages trigger heterotopic ossification in mice

We have identified a macrophage population "Mrep" that plays an essential role in muscle repair. However, in Fibrodysplasia ossificans progressiva (FOP), Mrep functions as a pathogenic cell that triggers heterotopic ossification.

18 Mar 2026